Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129


Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.

Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB.

J Am Acad Child Adolesc Psychiatry. 2008 Dec;47(12):1395-404. doi: 10.1097/CHI.0b013e31818914a1.


Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.

Emslie GJ, Kennard BD, Mayes TL, Nakonezny PA, Moore J, Jones JM, Foxwell AA, King J.

J Am Acad Child Adolesc Psychiatry. 2015 Dec;54(12):991-8. doi: 10.1016/j.jaac.2015.09.014. Epub 2015 Oct 8.


Sequential treatment with fluoxetine and relapse--prevention CBT to improve outcomes in pediatric depression.

Kennard BD, Emslie GJ, Mayes TL, Nakonezny PA, Jones JM, Foxwell AA, King J.

Am J Psychiatry. 2014 Oct;171(10):1083-90. doi: 10.1176/appi.ajp.2014.13111460.


A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.


Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team.

JAMA. 2004 Aug 18;292(7):807-20.


Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.

J Clin Psychopharmacol. 2002 Oct;22(5):474-80.


Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.

Faramarzi M, Alipor A, Esmaelzadeh S, Kheirkhah F, Poladi K, Pash H.

J Affect Disord. 2008 May;108(1-2):159-64. Epub 2007 Oct 23.


Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.

Rohde P, Silva SG, Tonev ST, Kennard BD, Vitiello B, Kratochvil CJ, Reinecke MA, Curry JF, Simons AD, March JS.

Arch Gen Psychiatry. 2008 Apr;65(4):447-55. doi: 10.1001/archpsyc.65.4.447.


Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.

Petersen T, Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE.

Psychol Med. 2004 Apr;34(3):555-61.


Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME.

JAMA Psychiatry. 2013 Nov;70(11):1152-60. doi: 10.1001/jamapsychiatry.2013.1969.


Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.

Asarnow JR, Emslie G, Clarke G, Wagner KD, Spirito A, Vitiello B, Iyengar S, Shamseddeen W, Ritz L, Mccracken J, Strober M, Suddath R, Leonard H, Porta G, Keller M, Brent D.

J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):330-9. doi: 10.1097/CHI.0b013e3181977476.


Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).

Lewis CC, Simons AD, Nguyen LJ, Murakami JL, Reid MW, Silva SG, March JS.

J Am Acad Child Adolesc Psychiatry. 2010 Feb;49(2):132-40.


The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.

Guidi J, Tomba E, Fava GA.

Am J Psychiatry. 2016 Feb 1;173(2):128-37. doi: 10.1176/appi.ajp.2015.15040476. Epub 2015 Oct 20. Review.


Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

J Consult Clin Psychol. 2014 Dec;82(6):1049-59. doi: 10.1037/a0037401. Epub 2014 Jul 21.


The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.


Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

Psychotherapy (Chic). 2015 Jun;52(2):268-77. doi: 10.1037/pst0000021.


Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.

Cornelius JR, Bukstein OG, Douaihy AB, Clark DB, Chung TA, Daley DC, Wood DS, Brown SJ.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):39-45. doi: 10.1016/j.drugalcdep.2010.05.010. Epub 2010 Jun 23.


Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder.

Tao R, Emslie G, Mayes T, Nakonezny P, Kennard B, Hughes C.

J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):71-8. doi: 10.1097/CHI.0b013e318190043e.


The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.

Davey CG, Chanen AM, Cotton SM, Hetrick SE, Kerr MJ, Berk M, Dean OM, Yuen K, Phelan M, Ratheesh A, Schäfer MR, Amminger GP, Parker AG, Piskulic D, Harrigan S, Mackinnon AJ, Harrison BJ, McGorry PD.

Trials. 2014 Nov 4;15:425. doi: 10.1186/1745-6215-15-425.

Supplemental Content

Support Center